Medicare Enrolled

Dr. Scott Bleazey, DPM

Foot & Ankle Surgery Podiatrist · Flemington, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
8100 WESCOTT DR, Flemington, NJ 08822
9087820600
In practice since 2011 (15 years)
NPI: 1144525973 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bleazey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bleazey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bleazey

Dr. Scott Bleazey is a foot & ankle surgery podiatrist in Flemington, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Bleazey performed 1,264 Medicare services across 894 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bleazey received a total of $13,036 from 18 pharmaceutical and/or device companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in foot & ankle surgery podiatrist. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bleazey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 49% volume in NJ $13,036 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,264
Medicare services
Top 49% in NJ for foot & ankle surgery podiatrist
894
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
252 $31 $140
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
204 $109 $205
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
203 $75 $153
Injection, methylprednisolone acetate, 40 mg 170 $6 $10
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
150 $85 $323
Ankle X-ray, minimum 3 views
An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints.
109 $33 $142
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
65 $50 $446
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
49 $49 $324
MRI of leg joint, without contrast
A magnetic resonance imaging scan of a joint in the leg performed without the use of contrast dye.
24 $179 $2,110
Foot nerve injection with anesthetic and/or steroid
An injection of an anesthetic and/or steroid medication into a nerve in the foot.
19 $46 $842
MRI of leg, without contrast
A magnetic resonance imaging scan of the leg performed without the use of contrast dye to visualize internal structures.
19 $208 $2,138
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,036
Total received (2018-2024)
Avg $1,862/year across 7 years
Top 10% in NJ for foot & ankle surgery podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
59
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,636 (66.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,360 (18.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,040 (15.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,162
2023
$287
2022
$657
2021
$71
2020
$2,084
2019
$7,662
2018
$1,113

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Maxx Health Inc
$1,039
Stryker Corporation
$63
Bioventus LLC
$29
Smith+Nephew, Inc.
$16
TREACE MEDICAL CONCEPTS, INC.
$15
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
Maxx Health Inc
$8,636
Wright Medical Technology, Inc.
$2,579
Stryker Corporation
$860
Kerecis Limited
$138
Celularity, Inc.
$125
Smith+Nephew, Inc.
$117
Integra LifeSciences Corporation
$99
Alliqua BioMedical, Inc.
$75
SeaPearl Inc
$71
TREACE MEDICAL CONCEPTS, INC.
$69
WRIGHT MEDICAL TECHNOLOGY, INC.
$64
Bioventus LLC
$58
Organogenesis Inc.
$48
Biocomposites Inc
$30
Stimwave Technologies Incorporated
$25
Zimmer Biomet Holdings, Inc.
$15
Derma Sciences, Inc.
$15
Paragon 28, Inc.
$12
Top 3 companies account for 92.6% of all-time payments
Associated products mentioned in payments ›
AMNIOEXCEL · AUGMENT INJECTABLE · AXSOS · BILAYER WOUND MATRIX BWM · BIOVANCE · BIOskin · CARTIVA · COLLAGENASE SANTYL · DUROLANE · Dermagraft · EBI Bone Healing System · FOOTPRINT · GELSYN 3 · INFINITY · Kerecis Omega3 SurgiClose · LAPIPLASTY SYSTEM · MICA · MIS Instrumentation · ORTHOLOC · OptOssol · PROMO · SALTO TALARIS TOTAL ANKLE PROSTHESIS · SALVATION · SIDEKICK · Santyl · Stimulan · Summa Ortho Foot · Summa Ortho Optossol · VARIAX · VITOSS · Varicom Screw
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 10% for foot & ankle surgery podiatrist in NJ.

Looking for a foot & ankle surgery podiatrist in Flemington?
Compare foot & ankle surgery podiatrists in the Flemington area by procedure volume, costs, and industry payment transparency.
Browse foot & ankle surgery podiatrists nearby

Geographic Context

Foot & ankle surgery podiatrists within 10 mi
85
Per 100K population
65.7
County median income
$139,453
Nearest hospital
HUNTERDON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bleazey is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 10% of NJ peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bleazey experienced with foot x-ray, 3+ views?
Based on Medicare claims data, Dr. Bleazey performed 252 foot x-ray, 3+ views services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bleazey receive payments from pharmaceutical companies?
Yes. Dr. Bleazey received a total of $13,036 from 18 companies across 59 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bleazey's costs compare to other foot & ankle surgery podiatrists in Flemington?
Dr. Bleazey's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bleazey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →